Skip to main content

Table 6 Univariate survival analysis for studied bladder carcinoma cases

From: ROC-1, P21 and CAIX as markers of tumor aggressiveness in bladder carcinoma in Egyptian patients

Variable

Overall survival (months)

Mean survival time

SE

Log rank

P-value

Gender

 Male

42.417

2.323

0.009

0.926

 Female

45.429

4.508

Age (years)

 ≤ 60

43.120

2.954

0.024

0.877

 > 60

42.209

2.979

Size of mass

 Absent

44.258

3.551

0.0

0.982

 Present

42.210

2.472

Diagnosis

 TCC

42.986

2.139

0.021

0.886

 Squamous ca

43.800

8.941

Grade

 Poorly diff

30.0

0.0

1.726

0.422

 Moderate differ.

47.250

10.872

 High

42.986

2.139

Bilharsiasis

 Absent

44.632

2.654

2.271

0.132

 Present

39.438

3.244

Necrosis

 Absent

43.615

2.475

0.047

0.829

 Present

40.857

3.787

LVI

 Absent

42.828

2.354

0.066

0.798

 Present

42.778

4.558

PNI

 Absent

43.537

2.203

1.211

0.271

 Present

37.833

6.263

Stroma

 Inflammatory

41.769

3.530

0.232

0.630

 Desmoplastic

43.252

2.559

Tumor stage

 T1

44.258

3.551

1.922

0.589

 T2

43.129

3.213

 T3

39.054

3.823

 T4

52.333

11.681

Ms invaion

 Absent

44.258

3.551

0.0

0.982

 Present

42.210

2.472

Node

 Absent

41.848

2.322

0.988

0.320

 Present

44.322

4.061

  

Reactivity (ROC-1 Immunohistochemistry)

 Negative

59.0

0.0

1.454

0.228

 Positive

42.100

2.095

Pattern (ROC-1 Immunohistochemistry)

 Negative

59.0

0.0

2.415

0.299

 Cytoplasmic

40.134

3.038

 Nuclear/cytopl

42.940

2.723

H score (ROC-1 Immunohistochemistry)

 Low median (< 90)

43.904

2.904

0.044

0.834

 High median (> 90)

41.947

2.987

IRS (ROC-1 Immunohistochemistry)

 Low

43.519

2.454

1.323

0.250

 High

40.700

3.950

Reactivity (CAIX Immunohistochemstry

 Negative

45.948

3.149

1.077

0.299

 Positive

40.856

2.703

Pattern (CAIX Immunohistochemstry

 Negative

45.948

3.149

1.077

0.299

 Cytoplasmic

40.856

2.703

H score (CAIX Immunohistochemstry

 Low median (< 90)

43.342

3.628

3.498

0.061

 High median (> 90)

36.500

3.591

  1. No comparison analysis was performed for urothelial carcinoma and squamous cell carcinoma grades because the factor variable had only one value
  2. CI Confidence interval